Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Researchers engineer antibody that broadly neutralizes a range of clade 1 sarbecoviruses

Researchers engineer antibody that broadly neutralizes a range of clade 1 sarbecoviruses

Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19

Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

Dynamic, customized treatment approaches for gastroesophageal cancers may improve survival rates

Dynamic, customized treatment approaches for gastroesophageal cancers may improve survival rates

Patients fend for themselves to access highly touted covid antibody treatments

Patients fend for themselves to access highly touted covid antibody treatments

Researchers develop new method for charting SARS-CoV-2 spike protein glycosylation

Researchers develop new method for charting SARS-CoV-2 spike protein glycosylation

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein

Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Researchers provide comprehensive molecular characterization of head and neck cancers

Researchers provide comprehensive molecular characterization of head and neck cancers

NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial

NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

New analysis method could pave the way for important breakthroughs in immunotherapy

New analysis method could pave the way for important breakthroughs in immunotherapy

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Osteoporosis drug also promotes infiltration of immune cells in breast tumors

Osteoporosis drug also promotes infiltration of immune cells in breast tumors